Get started
Author

Inês Soares de Pinho

Observed names: I Soares de Pinho, I. Soares De Pinho, I. Soares de Pinho, Inês Pinho, Inês Soares Pinho, Inês Soares-Pinho, Pinho, Inês
Observed institutions: University of Lisbon, Unidade Local de Saúde de Entre Douro e Vouga, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Instituto de Medicina Molecular João Lobo Antunes, Hospital CUF Descobertas, Centro Champalimaud, Unidade Local de Saúde Santa Maria, Comprehensive Health Research Centre, Universidade Nova de Lisboa
ORCID: 0000-0002-8377-0179
Observed ORCID: 0000-0002-8377-0179
OpenAlex ID: A5028219424
Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes
2023 · Lisa Gonçalves, Duarte Gonçalves, et al. · Cells · 39
PDF
Humoral Immune Response of SARS-CoV -2–Infected Patients with Cancer: Influencing Factors and Mechanisms
2021 · Miguel Esperança-Martins, Lisa Gonçalves, et al. · The Oncologist · 15
PDF
Predictive factors for pCR and relapse following neoadjuvant dual HER2-blockade in HER2+ breast cancer: an international cohort study
2025 · Paulo Luz, Raquel Lopes-Brás, et al. · Clinical & Translational Oncology · 11
PDF
Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence
2023 · Inês Soares de Pinho, Paulo Luz, et al. · Clinical Drug Investigation · 9
PDF
Exploring new pathways in endocrine-resistant breast cancer
2022 · Inês Soares de Pinho, Catarina Abreu, et al. · Exploration of Targeted Anti-tumor Therapy · 8
PDF
A case of corticosteroid-responsive SARS-CoV-2 related massive rhabdomyolysis
2020 · Maria Cunha, Inês Pinho, et al. · IDCases · 7
1724P Improving access to breast cancer diagnosis and treatment through navigation: Evaluation of a one-year pilot project in Botswana
2023 · A. Migeotte, I. Soares de Pinho, et al. · Annals of Oncology · 2
PDF
CDK4/6 Inhibitors-Induced Macrocytosis Is Not Associated with Hemolysis and Does Not Impact Hemoglobin Homeostasis
2025 · Tiago Barroso, Leila Costa, et al. · Cancers · 1
PDF
P11.54.a Brain Relapse in Her2-positive Breast Cancer After Neoadjuvant Treatment: an International Multicentric Study
2023 · A Fortuna, A Nobre Carvalho, et al. · Neuro-Oncology · 1
PDF
Real-World Use of Dostarlimab in Endometrial Cancer: A Portuguese Multicenter Study
2026 · Margarida Quinto Pereira, Pedro Antunes Meireles, et al. · Acta Médica Portuguesa
PDF
Multidisciplinary approach to advanced ovarian cancer surgery: A three-year single-centre experience with high complete cytoreduction rates and low severe morbidity
2026 · Rita Luz, Pedro Vieira, et al. · International Journal of Gynecological Cancer
Predicting Pathological Complete Response in HER2+ Breast Cancer: An AI-Driven Model Using Standard Clinical Practice Parameters
2025 · Paulo Luz, Enrique J. Alvarez Robles, et al. · Research Square
PDF
Abstract P1-03-03: Impact of Mainstreaming Protocol in Clinical Practice of Breast Cancer Patients
2025 · João Araújo, Inês Soares de Pinho, et al. · Clinical Cancer Research
Diagnosis and Management of Toxicities Associated with Immunotherapy in Cancer
2025 · Inês Soares de Pinho, João Araújo, et al. · Springer eBooks
A Case of Success: Complete Response to Radium-223 in Metastatic Castration-Resistant Prostate Cancer
2024 · Inês Soares de Pinho, Miguel Esperança-Martins, et al. · Cureus
PDF
Diagnosis and Management of Toxicities Associated with Immunotherapy in Cancer
2024 · Inês Soares de Pinho, João Araújo, et al. · Springer eBooks
A Case of Success With Immunotherapy After Changing the Therapeutics Strategy in Non-small Cell Lung Cancer
2023 · Bárbara Machado, Inês Soares de Pinho, et al. · Cureus
PDF
P159 Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio are not predictive of Pathologic Complete Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
2023 · I. Soares de Pinho, T. Barroso, et al. · The Breast
100P Immunotherapy around the clock: Impact on stage IV melanoma
2022 · L. Goncalves, D. Gonçalves, et al. · Immuno-Oncology Technology
Anthracycline versus no anthracycline neoadjuvant therapy for HER2 breast cancer: real world evidence
2022 · I. Soares De Pinho, D. Simão, et al. · European Journal of Cancer
High peripheral monocyte count is associated with increased risk of venous thromboembolism in patients with advanced pancreatic cancer
2022 · Sara Dâmaso, R. Paiva, et al. · Pancreatology
Works count: 22
Citation count: 93
H-index: 6
I10-index: 3
Year
Topic
Type